Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Shire
Company Monitoring Page for Shire
latest headlines for company on cafepharma
Takeda could rack up $10B in selloffs after controversial Shire buyout: report
Fierce Pharma
Fri, 11/30/18 - 12:22 pm
Tags:
Takeda
,
Shire
,
M&A
,
shareholders
Takeda clears final regulatory hurdle to completing its $62B Shire deal. Now only one obstacle remains
Endpoints
Tue, 11/20/18 - 12:17 pm
Tags:
Takeda
,
shareholders
,
Japan
,
M&A
,
Shire
,
Europe
Takeda investors mount last-minute effort to stymie Shire deal: FT
Fierce Pharma
Fri, 11/16/18 - 07:50 pm
Tags:
Takeda
,
Shire
,
shareholders
,
M&A
With the $62B Shire buyout on track, Takeda plans to debut the newly merged company at JPMorgan
Endpoints
Mon, 11/12/18 - 11:39 am
Tags:
Takeda
,
Shire
,
M&A
,
Christophe Weber
Exclusive: Takeda to win EU approval for US$62 billion Shire deal - sources
Channel News Asia
Sat, 11/10/18 - 12:40 pm
Tags:
Takeda
,
Shire
,
M&A
,
Europe
Takeda CEO confident about Shire merger
Pharmaforum
Thu, 11/8/18 - 09:44 am
Tags:
Takeda
,
Shire
,
M&A
,
shareholders
,
Pharma CEOs
,
Christophe Weber
Positive quarter from Takeda, waiting for completion of Shire deal
GoinPharma
Fri, 11/2/18 - 10:00 am
Tags:
Takeda
,
Shire
,
M&A
,
earnings
Takeda considering sale of OTC business in Europe ($11bn)
Bloomberg
Mon, 10/29/18 - 11:33 pm
Tags:
Takeda
,
Shire
,
M&A
,
OTC
Takeda is ready to auction off a PhIII favorite at Shire to clear the last hurdles to a $62B buyout
Enpoints
Sun, 10/28/18 - 07:47 pm
Tags:
Takeda
,
Shire
,
inflammatory bowel disease
,
IBD
,
ulcerative colitis
,
Crohn's Disease
,
M&A
,
SHP647
Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/27/18 - 12:16 pm
Tags:
BrainStorm Cell Therapeutics
,
Allergan
,
Pfizer
,
Clovis Oncology
,
Acorda Therapeutics
,
Takeda
,
Agios Pharmaceuticals
,
Shire
,
Teva Pharmaceutical
,
AbbVie
Shire's drug for rare swelling disorder wins European panel green light
Reuters
Sat, 10/20/18 - 11:04 pm
Tags:
EMA
,
Europe
,
Shire
,
Takhzyro
,
HAE
Panel backing for key Shire drug beefs up Takeda's case for its $62B buyout
Fierce Pharma
Fri, 10/19/18 - 11:46 am
Tags:
Shire
,
FDA
,
Takeda
,
M&A
FDA advisers back Shire constipation drug
Pharmaforum
Fri, 10/19/18 - 09:30 am
Tags:
FDA
,
Shire
,
advisory panels
,
prucalopride
,
CIC
,
chronic idiopathic constipation
Shire opens $1B plant to make rare disease drugs
Fierce Pharma
Sat, 10/13/18 - 10:47 pm
Tags:
Shire
,
Georgia
,
drug manufacturing
Cost-effectiveness doubts could hit Shire’s Takhzyro launch
EP Vantage
Fri, 10/12/18 - 11:43 pm
Tags:
Shire
,
Cinryze
,
Takhzyro
,
drug pricing
,
hereditary angiodema
Disgruntled Takeda alums demand a window into $62B Shire buy
Fierce Pharma
Thu, 10/4/18 - 12:07 pm
Tags:
Takeda
,
Shire
,
M&A
Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt
Bloomberg
Thu, 09/13/18 - 12:08 pm
Tags:
Takeda
,
Shire
,
M&A
,
Xiidra
Takeda shuttering Chicago complex with 1,000 staffers in lead-up to Shire merger
Endpoints
Tue, 09/11/18 - 11:33 pm
Tags:
Takeda
,
Shire
,
M&A
,
layoffs
Traditionalists at Takeda spark a family feud with CEO Christophe Weber over his $62B Shire takeover deal
Endpoints
Mon, 09/10/18 - 11:38 am
Tags:
Takeda
,
Pharma CEOs
,
Christophe Weber
,
Shire
,
M&A
FDA Approves Eight Novel Drugs in August
BioSpace
Sat, 09/1/18 - 04:17 pm
Tags:
Kyowa Hakko Kirin
,
Poteligeo
,
Alnylam
,
Onpattro
,
Amicus Therapeutics
,
Galafold
,
TherapeuticMD
,
Annovera
,
Biocodex
,
Diacomit
,
Dompe Group
,
Oxervate
,
Shire
,
Takhzyro
,
Merck
,
Pifeltro
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.